Fonds de solidarité FTQ commits $14.3 mln to Dutch life sciences fund
The Fonds de solidarité FTQ has made a $14.3 million commitment to the third fund of Forbion Capital Partners, a Dutch venture capital firm that invests in life sciences and biomedical technology sectors. The investment completes a recent cycle of fund commitments by the Fonds, which includes its participation in January's $134 million initial close of CTI Life Sciences' second fund. In the years ahead, the Fonds said it will shift its market focus to direct investments in life sciences companies. In the first quarter of 2015, the Fonds was one of the backers of new financings of enGene, an intestinal gene delivery platform, and of Thrasos Therapeutics, a biotherapeutics company.
25 May 2015•4 mins read
